Invitae Corporation, a San Francisco, CA-based genetic information company, completed a $120m Series F financing.
Backers included new investors The Broe Group, Decheng Capital, Deerfield Management LLC, OrbiMed, Perceptive Advisors, Rock Springs Capital and Wellington Management Company, LLP, and existing investors Casdin Capital, Genesys Capital, Genomic Health, Inc. (NASDAQ:GHDX), Randy Scott, Redmile Group and Thomas McNerney & Partners.
The company intends to use the funds to accelerate the build out of its infrastructure for its genetic information business, as well as to expand its global presence.
Invitae specializes in genetic diagnostics for hereditary disorders. The company currently provides a single diagnostic test comprising over 200 genes for a variety of genetic disorders associated with cancer, cardiology, neurology and pediatrics.
It has raised a total of $207m from investors to date.